RXRX Disposition Disclosure
Taylor Ben R · SEC Form 4 · Filed Sep 16, 2026
Disposition
Calculated transaction value
$18.4K
Taylor Ben R Chief Financial Officer
RXRX
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
RXRX daily price context
Close on/before transaction
$3.24
Sep 15, 2026
Close before public filing
$3.24
Sep 15, 2026
Return since public filing
+9.56%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 5,396 shares @ $3.41
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001601830-26-000110
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$18.4K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Disposition | Sep 15, 2026 | $18.4K |